Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP861787.RA175U4I_8E2-IBEb5w5hODyFwF15gl-nd1jTLbsnqE4U130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP861787.RA175U4I_8E2-IBEb5w5hODyFwF15gl-nd1jTLbsnqE4U130_assertion type Assertion NP861787.RA175U4I_8E2-IBEb5w5hODyFwF15gl-nd1jTLbsnqE4U130_head.
- NP861787.RA175U4I_8E2-IBEb5w5hODyFwF15gl-nd1jTLbsnqE4U130_assertion description "[There is also growing (although mixed) evidence that genotypes that appear to lead to reduced dopamine signaling (e.g., DRD2, DRD4, and DAT) and certain appetite-related hormones and peptides (e.g., ghrelin, orexin A, leptin) moderate the relation between dopamine signaling, overeating, and obesity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP861787.RA175U4I_8E2-IBEb5w5hODyFwF15gl-nd1jTLbsnqE4U130_provenance.
- NP861787.RA175U4I_8E2-IBEb5w5hODyFwF15gl-nd1jTLbsnqE4U130_assertion evidence source_evidence_literature NP861787.RA175U4I_8E2-IBEb5w5hODyFwF15gl-nd1jTLbsnqE4U130_provenance.
- NP861787.RA175U4I_8E2-IBEb5w5hODyFwF15gl-nd1jTLbsnqE4U130_assertion SIO_000772 21243471 NP861787.RA175U4I_8E2-IBEb5w5hODyFwF15gl-nd1jTLbsnqE4U130_provenance.
- NP861787.RA175U4I_8E2-IBEb5w5hODyFwF15gl-nd1jTLbsnqE4U130_assertion wasDerivedFrom befree-20140225 NP861787.RA175U4I_8E2-IBEb5w5hODyFwF15gl-nd1jTLbsnqE4U130_provenance.
- NP861787.RA175U4I_8E2-IBEb5w5hODyFwF15gl-nd1jTLbsnqE4U130_assertion wasGeneratedBy ECO_0000203 NP861787.RA175U4I_8E2-IBEb5w5hODyFwF15gl-nd1jTLbsnqE4U130_provenance.